Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Science (New York, N.Y.)|November 15, 2008
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancerSooryanarayana Varambally, Qi Cao, Ram-Shankar Mani, et al.Cancer Research|April 6, 2007
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinomaGuoan Chen, Xiaoju Wang, Jianjun Yu, et al.Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.Nature|August 3, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancerScott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, et al.Cancer Cell|March 28, 2017
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate CancerXiaoju Wang, Yuanyuan Qiao, Irfan A Asangani, et al.Molecular Cell|November 20, 2012
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancerIrfan A Asangani, Bushra Ateeq, Qi Cao, et al.Nature Immunology|November 3, 2015
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restrictionEnde Zhao, Tomasz Maj, Ilona Kryczek, et al.JCI Insight|July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.Cancer Cell|May 19, 2010
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionJindan Yu, Jianjun Yu, Ram-Shankar Mani, et al.Cancer Cell|August 16, 2011
Coordinated regulation of polycomb group complexes through microRNAs in cancerQi Cao, Ram-Shankar Mani, Bushra Ateeq, et al.Pageof 21